41 results
8-K
EX-10.1
f437e8oq8e2 h82dr
12 Oct 22
Entry into a Material Definitive Agreement
8:49am
8-K
EX-99.1
6tfvp8
4 Aug 22
Immune Therapeutics Appoints Chief Financial Officer and Chief Operating Officer
1:00pm
8-K
EX-10.1
xow0pu07xv2ka 8ri27
20 Mar 20
Immune Therapeutics, Inc. to Collaborate with Cytocom, Inc. to Develop Therapies for COVID-19
11:43am
S-1
wk2gtwk
14 Oct 16
IPO registration
12:00am
DRS/A
h3l53pr cl423
14 Oct 16
Draft registration statement (amended)
12:00am